| Diabetes Mellitus

Humulin R U-500 vs Novolog

Side-by-side clinical, coverage, and cost comparison for diabetes mellitus.
Deep comparison between: Humulin vs Insulin Diluting Medium For Novolog with Prescriber.AI
AI compares prescribing info and payer-specific access barriers across 1,200+ formularies. Here's a preview of what prescribers are already asking.
Safety signalsInsulin Diluting Medium For Novolog has a higher rate of injection site reactions vs Humulin based on FDA-approved prescribing information
Coverage gaps3 major payers require step therapy for Insulin Diluting Medium For Novolog but not Humulin, including UnitedHealthcare
Sign up to reveal the full AI analysis
Humulin
Insulin Diluting Medium For Novolog
At A Glance
SC injection
2-3 times daily
Human insulin
SC injection
Pre-meal
Rapid-acting insulin analog
Indications
  • Diabetes Mellitus
  • Diabetes Mellitus
Dosing
Diabetes Mellitus SC injection 2-3 times daily approximately 30 minutes before meals; individualize dose based on metabolic needs, blood glucose monitoring results, and glycemic control goal; do not mix with other insulins or administer IV.
Diabetes Mellitus Inject SC within 5-10 minutes before a meal into the abdominal area, thigh, buttocks, or upper arm; generally used with an intermediate- or long-acting insulin; may also be administered via continuous SC infusion pump or diluted to 0.05-1 unit/mL for IV infusion; individualize dose based on metabolic needs and blood glucose monitoring results.
Contraindications
  • Active episodes of hypoglycemia
  • Hypersensitivity to HUMULIN R U-500 or any of its excipients
  • Episodes of hypoglycemia
  • Hypersensitivity to NOVOLOG or one of its excipients
Adverse Reactions
Most common Hypoglycemia
Serious Severe allergic reactions including anaphylaxis, angioedema, bronchospasm, hypotension, shock; hypokalemia
Postmarketing Lipodystrophy, localized cutaneous amyloidosis, injection site reactions, weight gain, peripheral edema, anti-insulin antibodies
Most common (>=5%) Headache, accidental injury, nausea, diarrhea (type 1 diabetes); hyporeflexia, onychomycosis, sensory disturbance, urinary tract infection, chest pain, skin disorder, abdominal pain, sinusitis (type 2 diabetes)
Serious Severe hypoglycemia, generalized allergy/anaphylaxis, hypokalemia, lipodystrophy, peripheral edema
Postmarketing Localized cutaneous amyloidosis at injection site, medication errors with insulin substitution, hyperglycemia or hypoglycemia associated with amyloidosis-related injection site changes
Pharmacology
Human insulin; lowers blood glucose by stimulating peripheral glucose uptake in skeletal muscle and fat and inhibiting hepatic glucose production, and also inhibits lipolysis and proteolysis while enhancing protein synthesis.
Rapid-acting human insulin analog; regulates glucose metabolism by stimulating peripheral glucose uptake in skeletal muscle and fat and inhibiting hepatic glucose production, with peak glucose-lowering effect 1-3 hours after SC injection and duration of action 3-5 hours.
Enter your patient's insuranceCheck specific coverage details for your patient.
Most Common Insurance
Anthem BCBS
Humulin
  • Covered on 5 commercial plans
  • PA (10/12) · Step Therapy (1/12) · Qty limit (0/12)
View full coverage details ›
Insulin Diluting Medium For Novolog
  • Covered on 5 commercial plans
  • PA (5/12) · Step Therapy (5/12) · Qty limit (0/12)
View full coverage details ›
UnitedHealthcare
Humulin
  • Covered on 4 commercial plans
  • PA (1/8) · Step Therapy (0/8) · Qty limit (6/8)
View full coverage details ›
Insulin Diluting Medium For Novolog
  • Covered on 4 commercial plans
  • PA (0/8) · Step Therapy (0/8) · Qty limit (0/8)
View full coverage details ›
Humana
Humulin
  • Covered on 0 commercial plans
  • PA (0/3) · Step Therapy (0/3) · Qty limit (0/3)
View full coverage details ›
Insulin Diluting Medium For Novolog
  • Covered on 0 commercial plans
  • PA (1/3) · Step Therapy (0/3) · Qty limit (0/3)
View full coverage details ›
Coverage data sourced from MMIT. Updated monthly.
Savings
No savings programs available for Humulin.
No savings programs available for Insulin Diluting Medium For Novolog.
Compare Other Drugs
Let us handle your prior authsJust enter your patient's info and we'll:
  • Verify eligibility with the payer.
  • Pull the right PA forms directly from the payer.
  • Submit, track & send live updates to your dashboard.
Utilize patient records to autofill forms with our AI in seconds.
Free to start · HIPAA compliant
Next Steps for Your Patient
HumulinView full Humulin profile
Insulin Diluting Medium For NovologView full Insulin Diluting Medium For Novolog profile
Clinical data sourced from FDA-approved labeling. Coverage data via MMIT. Updated monthly.